...he German EUREKA Chairmanship 2009/2010! The confe...eral Ministry of Education and Research, will be h...ional Congress Center in Dresden, situated in the ... sights of Dresden., The conference will address ...s for Europe,s global competitiveness and the pote...
...developed countries in the wake of the obesity epi...with the condition. Foot problems are the most com...who are at risk of serious complications such as n...their feet. Both conditions can lead to slow-heali...ted and become gangrenous, can lead to amputation....
...College of Neuropsychopharmacology (ECNP) will be...y. , More than 6,500 clinical and basic scientis...sts and neuroscience researchers from all over the... largest annual high scientific standard congress ... Europe. Renowned experts from 25 countries will p...
Other Biology News:Protective footwear for diabetics at a high-street price 2Protective footwear for diabetics at a high-street price 3(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3... HEIGHTS, N.J., June 5 Genta,Incorporated (OTC Bul...y,has entered into definitive agreements with inst... Secured Convertible Notes due 2010 totaling in,ag... fees and expenses. The,closing of the first $20 m...out June 6, 2008, subject to the satisfaction of c...
...R, Mich., June 5 Compendia Bioscience today,annou...ment with,GlaxoSmithKline (NYSE: GSK ) for Oncomi...xtension Compendia,s flagship product, Oncomine.,O...s of Oncomine,Professional and Concepts editions b...tary gene expression data in comparison with exist...
...N FRANCISCO, Calif., June 5 Exelixis,Inc. (Nasdaq...ered into an,agreement with Deerfield Management, ...ignificant Exelixis stockholder, to provide Exelix...a flexible credit facility. The,funds can be drawn...iscretion. Exelixis is under no obligation to draw...
Other Biology Technology:Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 2Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 3Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 4GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience 2Exelixis Receives $150 Million Funding Commitment From Deerfield Management 2Exelixis Receives $150 Million Funding Commitment From Deerfield Management 3Exelixis Receives $150 Million Funding Commitment From Deerfield Management 4Exelixis Receives $150 Million Funding Commitment From Deerfield Management 5BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
Finnpipette Focus Multichannel 8 channel 5-50l from Thermo Scientific
...cal Form: buffered aqueous solution. Cleaves a-...lactose from complex carbohydrates and glycoprotei...nked galactose under conditions where the pH must ... Unit Definition: One unit will hydrolyze 1 mo...
...antibody is specific for human cardiac troponin su...the Ca-binding signals responsible for contraction...e troponin complex in human cells. It also cross-r...SA). Antigen: Highly purified human cardiac tr...
Biology Products: